UTI AMC Q1 FY27: Jul 23, 2026 earnings call at 4 PM

What UTI AMC has scheduled

UTI Asset Management Company Ltd. (NSE: UTIAMC, BSE: 543238) has lined up two closely watched events for its June quarter update. The board meeting is scheduled for July 22, 2026 to consider and approve the company’s Q1 FY27 results, as stated in the provided details. This will be followed by an earnings conference call on July 23, 2026 at 4:00 PM IST.

The call comes at a time when investors are seeking clearer visibility on systematic investment plan (SIP) flows, AUM trajectory, and operating cost discipline. The provided note also flags volatile market conditions and shifts in institutional equity flows as part of the broader context.

Key dates and quick snapshot

The disclosure highlights the near-term calendar and a set of market snapshot metrics that investors typically use as a starting point.

Why the July 23 call matters to investors

The stated purpose of the call is to discuss UTI AMC’s financial performance for Q1 FY27, with specific emphasis on AUM growth, revenue margins, and operational costs that influence valuation. In the same context, the material notes that the company’s “single-line agenda” is focused on growth, aiming to grow faster than peers in the Top 10 AMCs to potentially benefit from operating leverage.

The snapshot also describes UTI AMC as a Top 10 Indian AMC by AUM, positioning the discussion within a competitive segment where scale, distribution reach, and cost control can materially affect profitability. For investors, the management commentary on mix changes across equity, debt, passive, and cash management categories often matters as much as headline revenue.

Recent quarterly trend from the provided quarterly table

The quarterly results table (all figures in ₹ crore) provides a recent run of operating revenue and profitability.

For Mar 2026, operating revenue is listed at ₹317.04 crore, with net profit of ₹33.72 crore and an adjusted EPS of ₹2.62. This aligns closely with the “previous quarter” quick details that show revenue of ₹331 crore and PAT of ₹34 crore.

The table also shows that operating expenses rose to ₹253.34 crore in Mar 2026, compared with ₹142.66 crore in Dec 2025 and ₹135.66 crore in Mar 2025. Profit before tax (PBT) is shown at ₹62.96 crore in Mar 2026, versus ₹375.24 crore in Dec 2025.

Q1 FY27: what the market will likely track on the call

The provided material explicitly points to three core threads: SIP inflows, margin stability, and operating cost trends. It also states that the call will provide “specific data” on AUM growth, revenue margins, and operational costs.

In practical terms, investors typically map AUM growth to fee income, and fee income to operating leverage, especially in a mature AMC structure. Any discussion of employee costs is also closely watched, and the material indicates employee costs are expected to “stabilize” with quarterly run rates, though the exact run-rate number is not fully visible in the provided text.

Stock and valuation cues mentioned in the snapshot

The market snapshot in the extract places the stock around ₹924-₹935, while another line shows ₹914.45 on BSE at 01:36 PM, down 0.48%. The valuation snapshot mentions a P/E of 26.4 and market cap readings clustered around ₹12,000-₹12,400 crore.

These figures matter mainly as context heading into results and the management call. In AMCs, near-term price moves around results can be influenced by AUM commentary, distribution performance, and cost-to-income expectations.

A separate performance update cited in the material

The provided text also includes a separate update stating that UTI Asset Management reported a 17% increase in June quarter net profit to ₹274 crore versus ₹234 crore in the year-ago period, alongside a 13% rise in revenue to ₹529 crore (from ₹468 crore).

That update also lists AUM details: mutual fund business AUM rising 25% to ₹3.11 lakh crore (from ₹2.48 lakh crore), equity AUM up 22% to ₹88,606 crore, hybrid up 30% to ₹27,397 crore, fixed income up 20% to ₹29,724 crore, passive funds up 44% to ₹1.27 lakh crore, and cash management assets down 8% to ₹37,744 crore. It further notes SIP inflow up 13% to ₹624 crore and SIP AUM up **45% to ₹36,095 crore.

The same block states the shares closed 1% higher at ₹1,026.75 on the BSE in that instance.

Dividend and FY26 board outcome mentioned in the filing extract

A regulatory filing extract in the provided material states that, based on the audit committee’s recommendation, the board in its meeting held on April 23, 2026 approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.

It also recommended a final dividend of ₹40 per equity share for the financial year ended March 31, 2026, subject to shareholder approval at the ensuing AGM. The filing notes that results are also available on the company website in line with listing regulations.

Market impact: what is known from the provided information

From the information shared, the immediate market relevance is the results-and-call schedule, which sets expectations for when new numbers and management commentary will arrive. The snapshot also highlights the investor focus areas as SIP inflows, AUM growth, margin stability, and operational costs.

The quarterly table indicates that recent profitability has been sensitive to expense movements and other income, with Mar 2026 showing higher operating expenses and lower net profit than the preceding quarter in the table. Against that backdrop, the July 23 call is a key forum for management to explain the drivers that the market will quantify once Q1 FY27 numbers are disclosed.

Conclusion

UTI AMC’s July 22, 2026 board meeting and July 23, 2026 earnings call provide a clear timeline for Q1 FY27 updates. Investors will be watching the company’s commentary on AUM momentum, SIP trends, margins, and costs, alongside the headline quarterly financials once released.